Bladder Cancer

Photocure and Artera to Partner on Digital Pathology AI Test Evaluation for Bladder Cancer June 8, 2026

Impact of CKD on perioperative outcomes following TURBT: a national NSQIP analysis. June 8, 2026

Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics June 5, 2026

Epidemiological Trends and Germline Variant Analysis of Young-Onset Bladder Cancer. June 5, 2026

Sarcopenia Weakens the Benefit of Bacillus Calmette-Guérin in Non-Muscle-Invasive Bladder Cancer: A Computed Tomography-Based Cohort Study. June 5, 2026

An advanced in vitro bladder cancer model integrating bladder cancer spheroids into a healthy human urothelium for preclinical therapeutic testing. June 4, 2026

Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis. June 3, 2026

Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules. June 2, 2026

Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial. June 2, 2026

Unmet Treatment Need and Challenges Associated with Comparative Evidence Generation in BCG-unresponsive Non-muscle-invasive Bladder Cancer: An Expert Consensus. June 1, 2026

Survival Outcomes of a Smoking Cessation Treatment Program After Diagnosis of Bladder Cancer. June 8, 2026

Effect of marital status on years of life lost from metastatic bladder cancer according to sex and race/ethnicity. June 8, 2026

Collecting electronic patient-reported outcomes via smartphone text messages in a bladder cancer RCT: A feasibility study. June 5, 2026

Genomic analysis of BCG unresponsive non-muscle-invasive bladder cancer identifies drivers of sensitivity to intravesical Gemcitabine/Docetaxel. June 5, 2026

A machine-learning approach to predict additional treatment after Bacillus Calmette-Guérin induction in non-muscle-invasive bladder cancer. June 4, 2026

10-yr Outcomes of Senior Clinical Fellowship in Robot-assisted Radical Cystectomy (RARC) with focus on Intracorporeal Ileal Conduit Urinary Diversion: Aggregated Learning Curve Assessment and Achievement of the EAU-Robotic Urology Section (ERUS) RARC Curr June 4, 2026

Evolution of treatment and oncological outcomes in patients undergoing radical cystectomy: a comparative analysis across two decades at a tertiary center. June 3, 2026

What's next for VI-RADS? Updates and future perspectives from the ACR VI-RADS steering committee. June 2, 2026

AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy. June 1, 2026

Decoding Immune Mechanisms in BCG-unresponsive Non-muscle Invasive Bladder Cancer. June 1, 2026

Page 1 of 602